Saturday, July 11, 2026

pharma · Solid Tumors

JiaRay Group

JiaRay Group is a pharma organization headquartered in CN. Primary therapeutic focus areas include Solid Tumors. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from p

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Clinical program

JR8603

Phase 1 · small molecule · Solid Tumors

JR8603 for Solid Tumors is a Phase 1 program (small_molecule) at JiaRay Group with 1 ClinicalTrials.gov record(s).

← All JiaRay Group projects Phase 1 small molecule active

Internal code JR8603-9101

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
JiaRay Group
Phase
Phase 1
Modality
small_molecule
Indication
Solid Tumors
Status
active
Trials
1

Clinical trials